SEP 22, 2019 2:37 PM PDT

Genital Herpes Vaccine Works in Rodents

WRITTEN BY: Nouran Amin

A recent vaccine was developed by scientists at Perelman School of Medicine at the University of Pennsylvania that protects against genital herpes. The vaccine was administered on both mice and guinea pigs. Findings published in Science Immunology revealed "mostly sterilizing immunity" from the virus. This particular type of immunization is the strongest.

"We're extremely encouraged by the substantial immunizing effect our vaccine had in these animal models," said the study's principal investigator Harvey Friedman, MD, a professor of Infectious Diseases. "Based on these results, it is our hope that this vaccine could be translated into human studies to test both the safety and efficacy of our approach."

Using approaches in cutting edge cancer and immunotherapy studies, the developed vaccine was administered specifically to 64 mice that were then exposed to genital herpes. After 28 days, 63 of the mice displayed sterilizing immunity with no traces of the herpes infection and any evidence of the disease. The remaining mouse had a dormant infection without any priory genital herpes infection. The study was also applied to guinea pigs with similar results. Overall, no animal has developed genital lesions.

The vaccine, developed in collaboration between Penn Medicine and BioNTech, was filled with specific messenger RNA (mRNA) that creates proteins critical for strong immune responses. The vaccine stimulates three antibodies that block the herpes virus from entering cells and ensures that the virus doesn't "turn off" any innate immune system protective functions. Such an approach makes it unique than other methods for herpes vaccines because it often depends on inhibiting the entry of a virus.

Genital herpes, also known as the Herpes simplex virus type 2 or HSV-2, is the most common sexually-transmitted disease. Roughly 14 percent of Americans ages 14 to 59, and 11 percent of people in the same age range globally become infected. Symptoms include painful sores that spread to other areas of the body. The virus increases one's risk of getting HIV, and women who are infected and pregnant to threaten the fetus with infection particular during delivery.

"Along with physical symptoms, HSV-2 takes an emotional toll," said Friedman. "People worry over the transmission of the disease, and it can certainly have a negative effect on intimate relationships."

Learn more about genital herpes:

Source: Penn Medicine

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 17, 2020
Cancer
JAN 17, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells...
JAN 20, 2020
Cancer
JAN 20, 2020
Did you know these non-cancer drugs can also fight cancer?
A study from MIT. Harvard and the Dana-Farber Cancer Institute has concluded that almost 50 existing non-oncological drugs have anti-cancer properties capa...
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Drug Combo Targets Osteoarthritis
Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, s...
FEB 18, 2020
Microbiology
FEB 18, 2020
Newly Found Glycopeptide Antibiotics Kill Bacteria in a New Way
The overuse and misuse of antibiotics and the adaptability of microbes has created a problem that people must solve....
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
Treating stroke with low dose of clot-busting drug
A study concludes that a low-dose of the clot-busting drug—tenecteplase—may be beneficial for eligible stroke patients that do not need an inte...
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Could Effectively Treat a Lethal Blood Cancer
A pricey drug, called tyrosine kinase inhibitor (TKI), is used to continuously treat the blood cancer Chronic Myeloid Leukemia (CML). The TKI treatment, if...
Loading Comments...